Pharmacokinetics of Sedatives and Analgesics During Extracorporeal Membrane Oxygenation (ECMO) Support
Boston Children's Hospital
20 participants
Feb 8, 2019
OBSERVATIONAL
Conditions
Summary
This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.
Eligibility
Inclusion Criteria2
- supported on ECMO
- receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management
Exclusion Criteria1
- none
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Administered for sedation management per hospital protocol
Administered for sedation management per hospital protocol
Administered for sedation management per hospital protocol
Administered for sedation management per hospital protocol
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03593408